Illumina (ILMN)
(Delayed Data from NSDQ)
$131.20 USD
-3.19 (-2.37%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $131.08 -0.12 (-0.09%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth F Momentum D VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 31% (79 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.91 | 1.38 | 9.99 |
Current Quarter Estimate | 0.87 | 3.11 | 61.00 |
Year Ago Quarter Estimate | 0.33 | -4.81 | 54.84 |
Next Quarter Estimate | 0.92 | 3.91 | 63.00 |
Next Year Estimate | 4.43 | 24.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 322.09 | 17.30 | 15.67 |
Next Year | 22.04 | 9.90 | 11.34 |
Last 5 Years | -31.50 | 0.90 | 8.10 |
Next 5 Years | NA | 21.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 142.61 | -6.90 |
Price/Book (MRQ) | 14.55 | 2.10 |
Price/Cash Flow (MRFY) | 36.62 | 16.43 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -68.73% | -150.51% |
Return on Equity (TTM) | 3.08% | -61.16% |
Debt to Equity (MRQ) | 1.04 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.